NHFPC Chief Aims For Long-Term Reasonable Drug Pricing And Staff Pay
This article was originally published in PharmAsia News
Li Bin, China’s National Health and Family Planning Commission minister, said reasonable long-term drug pricing and staff pay are needed along with enforcement to curb bribery in pharmaceutical sales.
You may also be interested in...
Medtronic says that most of the clinical trials it is sponsoring are paused due to the pandemic, which means the completion of its PMA application for the Symplicity Spyral renal denervation system will be delayed.
Three-month results of the SPYRAL HTN-OFF MED pivotal trial show renal denervation with Medtronic’s Symplicity Spyral system significantly reduced blood pressure in hypertensive patients not taking anti-hypertensive medications.
Germany has ramped up its COVID-19 testing capacity to 260,000 per week, and still has a relatively low death rate from the virus. The country's diagnostics industry says it is ready to play its part “24/7.”